Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Why the Telstra (ASX:TLS) share price could be a buy again

The Telstra Corporation Ltd (ASX: TLS) share price could be a buy again after many years of hurting.

For years I haven’t been a fan of Telstra because of its profit declines, the NBN switch over and strong competition in the mobile space.

But things are starting to look up for Telstra shareholders.

A return to profit

Telstra recently said at its T25 strategy day that it is expecting mid-single digit underlying EBITDA (EBITDA explained) growth and high teen underlying profit/earnings per share (EPS) growth.

Profit growth has been missing from Telstra’s results for a number of years. The fact that it’s now expecting growth again is a positive sign.

Using the latest Telstra share price and CommSec estimates, the telco is valued at 24 times the estimated earnings for the 2023 financial year.

Further cost reductions

Revenue growth isn’t likely to be strong for Telstra.

But it has a plan to reduce costs by another $500 million to 2025. It’s a good sign that Telstra can continue to lower its cost base. Higher profit margins are what is most likely to help send the Telstra share price higher.

I also believe there is a big opportunity for Telstra to change household broadband connections from the NBN to a wireless 5G connection, this would significantly increase the profit margin generated on that household.

Earnings diversification

Telstra is a huge telco. But it could be a risky move to stay just operating purely as a telecommunications business forever.

The ASX blue chip share has been making moves to diversify its earnings for the long-term and open up new growth avenues.

For example, it recently announced the acquisition of MedicalDirector for a value of $350 million. This business is a clinical and practice management solution that supports GPs and other medical specialists to focus on providing high quality care and reducing time on paperwork and administration. It offers this solution as a software as a service (SaaS) model. MedicalDirector currently supports 23,000 medical practitioners and is used to deliver more than 80 million consultations a year.

Telstra Health has a vision of being a leading partner to the health and aged care sectors.

Growing dividends?

Telstra also said that as part of its T25 strategy it would like to get back to growing its dividend it can, when profit and franking credits allow.

Considering a lot of investors look at Telstra for the dividend, a growing dividend would be a really good change. At the latest Telstra share price, with its $0.16 per share annual dividend, it has a fully franked dividend yield of 4.1%.

Telstra seems to have turned a corner. Out of the ASX 20, it’d be one that I’d consider. However, I still believe there are plenty of ASX dividend shares with more growth potential.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content